Vimarsana
Biggest News Aggregation in the World

Syun Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Syun Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Syun Chen Today - Breaking & Trending Today

Immunotherapy for Alzheimer's disease shows promise in mouse study - The Source - Washington University in St. Louis - Vimarsana News

Immunotherapy for Alzheimer's disease shows promise in mouse study - The Source - Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have found a different and promising way to remove amyloid beta plaques in the brain: by directly mobilizing immune cells to consume them. The study was published in Science Translational Medicine.

Source: wustl.edu
Researchers find a promising approach to remove amyloid plaques in Alzheimer's disease - Vimarsana News

Researchers find a promising approach to remove amyloid plaques in Alzheimer's disease

Alzheimer's disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline.

Immunotherapy for Alzheimer's disease shows promise in mouse study - Vimarsana News

Immunotherapy for Alzheimer's disease shows promise in mouse study

Scientists at Washington University School of Medicine in St. Louis have shown that treating mice with an antibody that blocks the interaction between APOE prot

Immunotherapy Shows Promise as Alzheimer's Treatment - Vimarsana News

Immunotherapy Shows Promise as Alzheimer's Treatment

Researchers unveiled a novel approach to combat Alzheimer’s disease by activating microglia, the brain's immune cells, to devour amyloid beta plaques, a hallmark of the condition.

Immunotherapy for Alzheimer's disease shows promise in mouse study - Vimarsana News

Immunotherapy for Alzheimer's disease shows promise in mouse study

Scientists at Washington University School of Medicine in St. Louis have shown that treating mice with an antibody that blocks the interaction between APOE prot